AT THE END of December 2020, hope returned to the world, including hope for restarting travel, as countries began approving the Pfizer/BioNTech, Moderna, and Oxford-AstraZeneca vaccines. Sometime in 2021, when enough people are vaccinated against—and immune from—COVID-19, this could mean a return to globetrotting (or at least less-risky domestic vacations).
Yet anxiety surrounding travel isn’t going away as medical workers and older Americans begin to get jabbed. In the United States, people are still reluctant to plan future trips.
